lercanidipine

- During June a new agreement was concluded with Pharmathen S.A., a Greek pharmaceutical company, covering the exclusive, global and permanent license for Pharmathen's patent and technology as applied to lercanidipine IR (Immediate Release).

ITnews 2010

Therefore, competing generic versions manufactured by other producers can be marketed alongside the original Zanidip® and the other brands under which Recordati's lercanidipine based products are sold.

ITnews 2010

Company development highlights - Our new antihypertensive treatment based on a fixed association of lercanidipine with enalapril, was launched in a number of countries.

ITnews 2010

During April Recordati's subsidiary Bouchara Recordati launched the product as Zanextra® in France, the largest market for lercanidipine worldwide.

ITnews 2010

Recordati intends to eventually obtain approval in all countries where lercanidipine is currently marketed.

ITnews 2010

During February of this year the decentralized marketing approval procedure for this new lercanidipine formulation in a number of European countries was concluded favourably.

ITnews 2010

Regarding our expected results for the current year, 2010 will be affected by the competition from generics of lercanidipine whose patent expired in January.

EasyBourse : bourse en ligne, actualités financières 2010

Lee's Pharmaceutical Holdings (GEM: 8221), which is headquartered in Hong Kong, signed an exclusive license for China distribution of a Recordati S.p. A. [MI: RECI] antihypertensive drug, Zanidip® (lercanidipine) (see story).

SeekingAlpha.com: Home Page ChinaBio Today 2010

Furthermore, our new antihypertensive treatment, the fixed association of lercanidipine and enalapril, was launched in new markets which to-date total thirteen.

EasyBourse : bourse en ligne, actualités financières 2010

The new lercanidipine formulation developed by Pharmathen will be available in two dosages: 8 mg and

ITnews 2010